Abstract
Although COVID-19 is no longer a global public health threat, its consequences persist, with long COVID affecting at least 10% of patients and manifesting in various organ systems. National and international health agencies promoted vaccination to enhance population immunity, prioritizing healthcare personnel due to their high occupational risk. In a previous study, we found that the risk of SARS-CoV-2 transmission among dental teams in Germany was not higher than in the general population. This follow-up investigation aims to assess the vaccination status and the prevalence and severity of long COVID symptoms among dental teams in Germany. As part of a follow-up investigation involving the original cohort, 267 team members from 186 German dental practices previously included in the initial study completed an online questionnaire. The questionnaire covered three topics: (1) vaccination status, (2) confirmed COVID-19 diagnosis, and (3) self-reported long COVID symptoms. One hundred and seventy-two dentists (64.4%), 74 dental assistants (27.7%) and 21 dental hygienists (7.9%) completed the questionnaire. In total, 245 participants (91.8%) were at least once vaccinated. A COVID-19 infection after January 1st 2021 was reported by 146 (54.7%) participants, of which 33 participants (22.6%) suffered from long COVID symptoms. Our results showed lower vaccination rates among dental auxiliary personnel compared to dentists (95.9% vs. 84.2%). Individuals with long COVID symptoms were more often dental assistants (48.5% vs. 29.2%) or dental hygienists (15.2% vs. 8.0%) than dentists (36.4% vs. 62.8%) compared to the group not reporting long COVID symptoms (p = 0.025). In addition, it is unlikely that dental healthcare personnel are more prone to experiencing more severe symptoms compared to the general population. Vaccination against SARS-CoV-2 is likely to help against symptoms of long COVID.
Similar content being viewed by others
Introduction
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected approximately 775 million people globally (as of August 5th 2024)1. Initial efforts to contain the spread of the virus focused primarily on preventive measures such as physical distancing and mandatory face masks2. On December 21st 2020, the European Commission conditionally authorized the first vaccine against the coronavirus disease (COVID-19) for people aged 16 years and older3. Subsequently, several vaccines have been authorized and administered worldwide4. Public awareness campaigns around the world emphasized the importance of immediate vaccination. Those campaigns were based on numerous studies reporting various benefits of the COVID-19 vaccine including enhanced protection from severe complications, reduced need for hospitalization and mechanical ventilation5,6. As of November 2023, approximately 67% of the world’s population had received a complete primary series of a COVID-19 vaccine7. This marked the transition from the pandemic response phase to pandemic control.
Despite the decline of corona-related hospital admissions and deaths, the consequences of the pandemic still persist8,9. These consequences manifest as multisystem conditions with diverse symptoms following an infection with the SARS-CoV-2 virus, often referred to as post-acute sequelae of COVID-19 or long COVID10. Long COVID is defined by the World Health Organization (WHO) as the continuation or development of new symptoms at least three months after COVID-19 infection and lasting for at least two months with no sufficient explanation by alternative diagnoses11. It is roughly estimated that at least 10% of individuals infected by SARS-CoV-2 suffer from long COVID, although the real number is probably much higher due to undocumented and untreated cases12,13. Fatigue, exhaustion, dyspnea, and lack of concentration are constantly reported as the most common long COVID symptoms14. Due to the lack of effective treatment approaches, this condition poses a significant challenge to healthcare systems in both the short and long-term. Furthermore, the additional costs associated with protective measures, such as screening, testing, and personal protective equipment, have placed a substantial economic burden on healthcare facilities, and private practitioners alike15,16. A complicating factor when analyzing the prevalence of long COVID is accurately defining the onset time, whether before or after COVID infection. Some of those symptoms may have been mildly present before COVID-19 infection but worsened afterwards.
Dental personnel are known to work in the oral cavity, a body region with potentially high respiratory viral and bacterial load. Due to the high number of dental procedures resulting in the spread of infectious respiratory particles, dental healthcare personnel were thought to suffer from an increased risk of exposure to SARS-CoV-217. At the early stages of the pandemic, healthcare authorities worldwide issued various guidelines concerning the virus and its transmission routes. These guidelines, based on little research and information, varied significantly, presenting challenges for patients and healthcare providers. Since then, occupational risk among dental healthcare personnel has been well examined18, confirming that with appropriate infection control measures, the risk of infection can be mitigated19. Nevertheless, the particularity of the setting in the dental praxis with the fear of contracting the virus from proximate patients and infectious respiratory particles generated during dental procedures increased the psychological pressure on oral healthcare personnel since the outbreak of the pandemic20. Psychological distress has been reported to contribute to physical complaints particularly among dental healthcare personnel at the beginning of the pandemic21,22.
In a previous study conducted between January and March 2021, we examined the hazard of SARS-CoV-2 infection among German dental teams (n = 2784 team members of 186 German dental practices). The overall test positivity rate for SARS-CoV-2 antibodies among dental healthcare workers was 5.2%. We have followed up this population to assess the coronavirus vaccination rate and symptoms of long COVID based on an online questionnaire.
Materials and methods
Recruitment
In a previous study, we analyzed data from 2784 individuals who worked at 1390 licensed dental practices in 5 urban regions in Germany between January and April 202123. During the study period, we obtained their consent to contact them again for a follow-up investigation. The follow-up study protocol was approved by the Ethical Committee of the University Medicine Greifswald (BB 081/20b October 06th 2022). All participants signed an informed consent. All study procedures were conducted in accordance with the ethical standards as laid down in the Declaration of Helsinki.
Between November and December 2022, we re-invited the participants from the baseline study to participate in a follow-up investigation. The invitation included a link to answer an online questionnaire with the same numerical identifier (ID) used during the previous study to ensure data privacy and enable the matching of information regarding previous infection and vaccination from both investigations. Our follow-up sample consisted of 267 participants (Supplementary Fig. 1).
Data collection/online questionnaire
The online questionnaire was divided into three parts. The first part focused on the vaccination status of the participants including the number of doses received and the type of vaccine used. The second part consisted of information on confirmed COVID-19 diagnosis based on polymerase chain reaction (PCR) assays and the reason for taking the test, as well as the course of infection and need of hospitalization or admission to intensive care unit (ICU). The third part evaluated long COVID symptoms reported by the participants and the impact of these symptoms on their daily life. We inquired information about prevalent symptoms known to be associated with coronavirus disease including fatigue, exhaustion, dyspnea (shortness of breath), coughing, lack of concentration, headache, dysgeusia (distortion of the sense of taste), anosmia (partial or full loss of smell), muscle pain, limb pain, chest pain, joint pain, sleeping disorder, depression heart stumble, and palpitation24. The severity of the symptoms was categorized based on the impact on daily activities as follows: (1) No impairment, (2) Negligible impairment, (3) Moderate impairment, (4) Severe impairment, (5) care needed. Reported long COVID symptoms as well as severity of symptoms were based on subjective perception only. All procedures complied with national privacy and data protection laws in Germany and were reviewed in advance by the University Medicine Greifswald’s data protection officer.
Statistical analysis
Continuous data was reported by means and standard deviations (SD). Categorical data was described by absolute numbers and percentages. Differences in continuous variables across groups were evaluated by t-tests, while differences in categorical variables were tested by Chi squared tests. A p < 0.05 was considered as statistically significant. Data was analyzed with Stata 18.0.
Results
We received responses from 201 women and 66 men aged 18 to 73 years (mean age 49 years; SD 10 years) from 186 dental practices. Among the participants were 172 dentists (64.4%), 74 dental assistants (27.7%), and 21 dental hygienists (7.9%); Table 1. Overall, 245 (91.8%) participants were at least once vaccinated, 244 (91.4%) twice vaccinated, 219 (82.0%) three times vaccinated, and 54 (20.2%) four times vaccinated (Fig. 1). The vaccination frequency differed significantly between dentists (95.9%) and dental auxiliary personnel (i.e. dental assistants and hygienists; 84.2%) (p = 0.001).
Since January 1st 2021, 146 (54.7%) participants reported COVID-19 infection as ascertained by a PCR testing. Infections were more common among dental auxiliary personnel (66.3%) than dentists (48.3%; p = 0.005). Of the 146 participants infected with COVID, 33 (22.0%) participants reported suffering from at least one long COVID symptom. The mean age was not significantly different between those with (46.3 years; SD 10.3) and those without (47.5 years; SD 11.1) long COVID symptoms (p = 0.588), nor was the percentage of women. The frequency of women was slightly higher but not significantly different in the long COVID group compared to individuals not reporting long COVID symptoms (87.1% vs. 81.1%; p = 0.442). Individuals with long COVID symptoms were more often dental assistants (long COVID 48.5% vs. no long COVID 29.2%) or dental hygienists (15.2% vs. 8.0%) than dentists (36.4% vs. 62.8%) compared to the group not reporting long COVID symptoms (p = 0.025). The frequency of COVID-19-vaccination was slightly lower in individuals with long COVID symptoms than in individuals without long COVID symptoms (81.8% vs. 90.3%; p = 0.183).
On average, participants with long COVID reported 5.5 symptoms. The frequencies of each symptom are illustrated in Fig. 2. The most common symptoms were exhaustion, fatigue, and lack of concentration and the most common severe symptoms were fatigue, exhaustion, limb and muscle pain. The impact of the reported long COVID symptoms on daily activity is shown in Table 2; Fig. 3.
we have calculated a severity sum-score, where we summed up all 16 items. For “no impairment” one point was added, for “negligible impairment” two points were added, for “moderate impairment” three points were added, for “severe impairment” four points were added, and for “care needed” five points were added. The resulting severity score had a median of 32.5 points with an interquartile range from 25.5 to 43.5 points in individuals with at least one long COVID symptom. In linear regression models, sex (male vs. female: β = −2.0; 95% confidence interval [CI] = −13.7 to 9.7; p = 0.726), vaccination status (no vs. yes: β = 4.2; 95%-CI = −5.8 to 14.2; p = 0.396), and occupational group (dental assistant or dental hygienists vs. dentist: β = 3.4; 95%-CI = −4.9 to 11.6; p = 0.409) were not significantly associated with COVID symptoms in the long COVID group.
Discussion
Vaccination rates among the dental team members in Germany were much higher than in the general population. The vaccination rate in the dental team was very high, 82% of the team had at least 3 vaccinations. By contrast, by April 2023 62.6% of the German population had been vaccinated twice and only 15.2% had been vaccinated three times25.
The dental team witnessed a turning point in March-April 2020 after the outbreak of the pandemic. Forced closure and shortage of personal protective equipment caused fear and anxiety among dental teams and their patients26. Authorization of the first vaccine promised a milder course of disease and enhanced protection from future infection27. This achievement was embraced with optimism, offering a relief in time of uncertainty. Despite emerging reports of serious side effects following vaccine administration, dentists and their teams were not reluctant to follow the recommendations of national and international health agencies28. The acceptance rate of the COVID vaccine varied greatly across countries (33-97.5%), showing a significant positive association between country income and vaccine acceptance29,30. Other studies suggest that the intention to be vaccinated is correlated with the perceived risk of infection31. Globally, the perceived risk of infection among dental healthcare personnel was extremely high32,33, which explains the notably high percentage of vaccination rate among our sample compared to the general population.
In our sample, we noticed a slightly higher vaccination rate among dentists (95.5%) compared to 84.2% among dental auxiliary personnel. Vaccine hesitancy among healthcare workers is a known complicated multidimensional matter. In Europe, previous research has shown that low socioeconomic status has been a significant obstacle to vaccination against various diseases34,35. Additionally, an access to scientifically accurate and up-to-date vaccine information leads to a positive attitude towards vaccination36. Our results align with various studies that reported higher vaccination rates among general practitioners and dentists compared to nurses and dental assistants37. Although there is not a definite explanation for this phenomenon, several factors may contribute to the differences between these two crucial occupational groups. We presume that a lower socioeconomic status, less vaccination literacy, adverse influence by media coverage, and less trust in pharmaceutical industry / health authorities might be possible explanations for the lower vaccination rates among dental auxiliary personnel.
Unfortunately, there are multiple definitions for long COVID, varying in their time frame for symptoms onset and duration. The WHO defines long COVID symptoms lasting for at least 2 months11, whereas the U.S. Centers for Disease Control and Prevention (CDC) requires symptoms to be present for at least 3 months38. However, neither organization specifies the nature or number of symptoms required to make a diagnosis. Based on extensive follow-up studies conducted since the outbreak of the pandemic, researchers have compiled a list of over 200 symptoms observed in patients suffering from long COVID39. The broad definition of long COVID on one hand and the lack of a specific biomarker or exclusive symptoms on the other hand, poses a challenge for establishing a consensus in research approaches. This variability makes the comparability and generalization of results across different studies particularly difficult. Symptoms of long COVID may resolve over a period of months for most patients or can persist for years40. A limitation to our results is that we do not know if our participants have a confirmed medical diagnosis for long COVID or if they fit the global definition. However, our results align with published research examining common long COVID symptoms. Fatigue and exhaustion are the most frequently reported symptoms in our sample (Table 2), leading in almost 40% of the cases to a decrease in daily activities. Interestingly, those symptoms were more pronounced among dental assistants than among dentists. Furthermore, 7 out of 32 (21.9%) participants reported reducing working hours due to long COVID. Several studies have discussed the association between employment status and sickness presenteeism (going to work while being ill)41. In the pandemic era, the number of sick notes increased and sick notes were more frequently issued to people with a COVID-19 infection than those without, even in times when most people were already vaccinated42. Considering those findings, we can only assume that auxiliary team members tend to take longer to return to work whilst the owner of the practice might return earlier to work.
Reported incidence of long COVID varies greatly (8–35%)14,39. Those variation can be attributed to several factors including definition of long COVID, study design, diagnostic methods, targeted demographics and duration of follow-up. Higher incidences were reported among hospitalized cases and particularly among adults aged ≥ 65 years43. The exact pathophysiology causing long COVID is still unknown challenging clinicians and researchers alike. Several hypotheses have been presented, each suggesting potential overlapping mechanisms contributing to the persistence of symptoms beyond the acute phase of infection. One hypothesis suggests the presence of a lingering reservoir of SARS-CoV-2 in specific tissues, evading clearance by the immune system and perpetuating ongoing symptoms44. Additionally, immunological dysfunction has been implicated as a potential cause of long COVID symptoms45. Dysregulated immune responses may result in prolonged inflammation and tissue damage, contributing to the chronicity of symptoms experienced by affected individuals. Furthermore, emerging evidence suggests a potential link between alterations in the gut microbiota and persistence of COVID-19 symptoms46. Moreover, the reactivation of underlying pathogens has been proposed as another potential mechanism contributing to the prolonged course of illness observed in some individuals47.
We observed a 10% difference in the incidence of long COVID between vaccinated and non-vaccinated dental team members. However, due to the small number of subjects with long COVID, we can not conclusively determine if unvaccinated dental healthcare personnel are more susceptible to suffer from long COVID or experience more severe symptoms. Al-Aly et al.48 conducted a comprehensive analysis using data from the electronic healthcare database of the U.S. Department of Veterans Affairs examining long COVID symptoms 6-months post infection in 33,940 individuals with a breakthrough COVID infection and several controls without evidence of COVID infection, including contemporary (n = 4,983,491), historical (n = 5,785,273) and vaccinated (n = 2,566,369) controls. The study compared the risk for long COVID symptoms among vaccinated and unvaccinated participants. Participants who were previously vaccinated showed lower risk of developing 24 of the 47 examined symptoms. This risk mitigation became more evident as the care setting changed from non-hospitalized to requiring ICU-admission. Our results confirm established knowledge and are in line with the findings from Al-Aly et al.48. However, it is crucial to acknowledge that while vaccination offers partial protection against the development of long COVID and mortality, it does not guarantee complete immunity. Consequently, relying solely on vaccination to contain the consequences of COVID infection would not be an optimal approach.
Our study focused on a specific occupational cohort. To our knowledge, this is the first study to examine the prevalence and severity of long COVID among dental healthcare personnel in Germany. As a follow-up investigation, this study has some limitations. The selection of our participants was not representative, because we were bound by the informed consent of participants of our baseline examination. Another larger limitation is the low response rate for the follow-up questionnaire. Furthermore, data on symptoms of long COVID were based on self-reported response and may not be medically confirmed. It was also not possible to accurately calculate the time from infection to onset of symptoms of long COVID and how long it lasted. Despite these limitations, our study offers valuable insights into the prevalence and characteristics of long COVID within the dental healthcare sector in Germany. For following projects, it would be interesting to focus on individuals reporting long COVID symptoms who have received professional medical therapy and to examine its long-term effects.
Conclusion and clinical implication
Our findings indicate that vaccination rates were lower among dental auxiliary personnel compared to dentists. Furthermore, individuals experiencing long COVID symptoms were more frequently dental assistants or dental hygienists than dentists when compared to those without long COVID symptoms. Additionally, our results suggest that dental healthcare personnel are not at a higher risk of experiencing more severe long COVID symptoms than the general population.
Data availability
The datasets generated during and/or analyzed during the current study are not publicly available due to the data protection act. Deidentified individual participant data that underlie the results reported in this manuscript will be available to the scientific community on request. Applicants interested must provide a proposal form which entails the scientific aim of the usage of the data provided and the institutional review board approval of the research proposal. All proposals should be directed to the corresponding author.
References
World Health Organisation. WHO COVID-19 dashboard. (2024).
Chu, D. K. et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet 395 (10242), 1973–1987 (2020).
European Commission. European Commission approves first COVID-19 vaccine. (2020). Available from: https://www.eu2020.de/eu2020-en/news/article/european-commission-approves-first-covid-19-vaccine/2430420
Grapsa, E. et al. Association between vaccination status and mortality among intubated patients with COVID-19-Related acute respiratory distress syndrome. JAMA Netw. Open. 5 (10), e2235219 (2022).
Tenforde, M. W. et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. Jama 326 (20), 2043–2054 (2021).
Watanabe, A. et al. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine 41 (11), 1783–1790 (2023).
World Health Organisation. WHO COVID-19 dashboard. [cited 2024 August 5th, 2024]; (2024). Available from: https://data.who.int/dashboards/covid19/vaccines?n=c
Prevention, C. f.D.C.a. COVID Data Tracker. U.S. Department of Health and Human Services, CDC;: Atlanta, GA. (2024).
Control, E. C. f.D.P.a. Hospital and ICU admission rates and occupancy for COVID-19. (2024).
Davis, H. E. et al. Author correction: long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21 (6), 408–408 (2023).
World Health Organisation. Post COVID-19 condition (Long COVID). (2022).
World Health Organisation. Post COVID-19 condition (Long COVID). [cited 2024 January 29th 2024]; (2022). Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition
Saade, A. et al. The prevalence, determinants, and consequences of post-COVID in healthcare workers: A cross-sectional survey. J. Med. Virol. 96 (6), e29725 (2024).
Ceban, F. et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 101, 93–135 (2022).
Vardavas, C. et al. Cost of the COVID-19 pandemic versus the cost-effectiveness of mitigation strategies in EU/UK/OECD: A systematic review. BMJ Open. 13 (10), e077602 (2023).
Santamaria, M. et al. Infection concerns and economic burden: Dentists’ cancellations during COVID-19. Int. Dent. J. 74 (2), 276–283 (2024).
Wolf, T. G. et al. How the COVID-19 pandemic affects risk awareness in dentists: A scoping review. Int. J. Environ. Res. Public Health. 19 (9), 4971 (2022).
Campus, G. et al. The COVID-19 pandemic and its global effects on dental practice. An international survey. J. Dent., 114, 103749. (2021).
Choi, S. E. et al. Evaluation of comprehensive COVID-19 testing program outcomes in a US dental clinical care academic setting. JAMA Netw. Open. 5 (12), e2246530–e2246530 (2022).
Shabestari, M. et al. One year of COVID-19 in dental health services in Norway: Psychological impact, risk perceptions and vaccination status. BMC Health Serv. Res. 23 (1), 972 (2023).
Salehiniya, H. & Abbaszadeh, H. Prevalence of corona-associated anxiety and mental health disorder among dentists during the COVID-19 pandemic. Neuropsychopharmacol. Rep. 41 (2), 223–229 (2021).
De Haro, J. C. et al. Psychological impact of COVID-19 in the setting of dentistry: A review Article. Int. J. Environ. Res. Public. Health, 19(23), 16216. (2022).
Mksoud, M. et al. Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany. Clin. Oral Investig. 26 (5), 3965–3974 (2022).
Mizrahi, B. et al. Longitudinal symptom dynamics of COVID-19 infection. Nat. Commun. 11 (1), 6208 (2020).
Gesundheit, B. Übersicht zum Impfstatus. (2024).
Daltaban, Ö. & Aytekin, Z. Fear and anxiety of COVID-19 in dental patients during the COVID-19 pandemic: A cross-sectional survey in Turkey. Dent. Med. Probl. 59 (3), 343–350 (2022).
Li, M. et al. COVID-19 vaccine development: Milestones, lessons and prospects. Signal. Transduct. Target. Ther. 7 (1), 146 (2022).
Majumder, M. A. A. et al. Evaluation of Short-Term side effects following the first dose of COVID-19 vaccines among physicians and dentists: A Cross-Sectional study from India. J. Multidiscip Healthc. 16, 161–174 (2023).
Nassani, M. Z. et al. Determinants of COVID-19 vaccine acceptance among dental professionals: A Multi-Country survey. Vaccines (Basel), 10(10), 1614 (2022).
Lin, G. S. S. et al. COVID-19 vaccination acceptance among dental students and dental practitioners: A systematic review and meta-analysis. PLoS One. 17 (4), e0267354 (2022).
Galanis, P. et al. Intention of healthcare workers to accept COVID-19 vaccination and related factors: A systematic review and meta-analysis. Asian Pac. J. Trop. Med. 14 (12), 543–554 (2021).
Belingheri, M. et al. COVID-19 vaccine hesitancy and reasons for or against adherence among dentists. J. Am. Dent. Assoc. 152 (9), 740–746 (2021).
Aldakhlan, H. A., Khan, A. S. & Alabdulbaqi, D. Hesitancy over the COVID-19 vaccine among various healthcare workers: An international narrative review. Cureus 16 (1), e53059 (2024).
Costantino, C. et al. Systematic review and meta-analysis of determinants associated with HPV vaccination uptake in Europe. Eur. J. Pub. Health.. 30 (Supplement_5), ckaa166-1438 (2020).
Wilder-Smith, A. B. & Qureshi, K. Resurgence of measles in Europe: A systematic review on parental attitudes and beliefs of measles vaccine. J. Epidemiol. Glob Health. 10 (1), 46–58 (2020).
Paris, C. et al. COVID-19 vaccine hesitancy among healthcare workers. Infect. Dis. Now. 51 (5), 484–487 (2021).
Kaur, M., Coppeta, L. & Olesen, O. F. Vaccine hesitancy among healthcare workers in Europe: A systematic review. Vaccines (Basel), 11(11), 1657 (2023).
Prevention, U. S. C.f.D.C.a. Long. COVID Basics (2024).
National Academies of Sciences, E. and & Medicine in A long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences. 186 (eds Fineberg, H. V.) (National Academies, 2024).
Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019 (2021).
Park, J. W. et al. Association between employment status and sickness presenteeism among Korean employees: A cross-sectional study. Ann. Occup. Environ. Med. 32, e17 (2020).
Schaffer, A. L. et al. Changes in sick notes associated with COVID-19 from 2020 to 2022: A cohort study in 24 million primary care patients in OpenSAFELY-TPP. BMJ Open. 14 (7), e080600 (2024).
Bull-Otterson, L. et al. Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥ 65 Years — United States, March 2020–November 2021. (0149–2195 (Print)).
Swank, Z. et al. Persistent Circulating severe acute respiratory syndrome coronavirus 2 Spike is associated with Post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 76 (3), e487–e490 (2023).
Phetsouphanh, C. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23 (2), 210–216 (2022).
Liu, Q. et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 71 (3), 544–552 (2022).
Zubchenko, S. et al. Herpesvirus infections and post-COVID-19 manifestations: A pilot observational study. Rheumatol. Int. 42 (9), 1523–1530 (2022).
Al-Aly, Z., Bowe, B. & Xie, Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28 (7), 1461–1467 (2022).
Acknowledgements
This publication was funded by the German Federal Ministry of Education and Research (BMBF) Network of University Medicine 2.0: “NUM 2.0”, Grant No. 01KX2121, Project: Collateral Effects in Pandemics – CollPan.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
M.M. contributed to conception, design, data analysis and interpretation, drafted and critically revised the manuscriptT.I contributed to conception, design, performed all statistical analyses, drafted and critically revised the manuscriptB.H. contributed to conception, design, data interpretation, drafted and critically revised the manuscriptA.S contributed to conception, and critically revised the manuscriptC.S. contributed to conception, data acquisition, and critically revised the manuscriptA.W. contributed to conception, design, data interpretation, and critically revised the manuscriptS.P. contributed to conception, design, and critically revised the manuscriptF.M. contributed to data acquisition and interpretation, and critically revised the manuscriptA.W. contributed to conception, design, and critically revised the manuscriptP.K. contributed to conception, design, and critically revised the manuscriptA.R. contributed to conception, design, and critically revised the manuscriptS.K. contributed to conception, design, data interpretation, drafted and critically revised the manuscriptT.K. contributed to conception, design, data interpretation, drafted and critically revised the manuscriptAll authors gave their final approval and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mksoud, M., Ittermann, T., Holtfreter, B. et al. Vaccination rate and symptoms of long COVID among dental teams in Germany. Sci Rep 15, 13654 (2025). https://doi.org/10.1038/s41598-025-96670-8
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-025-96670-8





